Metformin is a biguanide drug that has been used to treat type 2 diabetes mellitus for more
than 60 years. The United Kingdom Prospective Diabetic Study (UKPDS) has shown …

Non-alcoholic fatty liver disease (NAFLD) represents the most common chronic liver disease
in industrialized countries. NAFLD progresses through the inflammatory phase of non …

Sažetak Diabetes is a complex, heterogeneous condition that has beta cell dysfunction at its
core. Many factors (eg hyperglycemia/glucotoxicity, lipotoxicity, autoimmunity, inflammation …

Despite our cognizance that diabetes can enhance the chances of heart failure, causes
multiorgan failure, and contributes to morbidity and mortality, it is rapidly increasing menace …

Although the presence of cardiac dysfunction and cardiomyopathy in chronic diabetes has
been recognized, the pathophysiology of diabetes-induced metabolic and subcellular …

Metformin (MET) has been demonstrated to have favorable impact on nonalcoholic fatty liver
disease (NAFLD); however, the combined effect of this drug with p-coumaric acid (PCA) on …

Background Synsepalum dulcificum is a plant indigenous to West Africa. The fruit is used to
modify taste of foods to sweetness. Objectives This study aims to investigate the antidiabetic …

Background: Oxidative stress is involved in the pathophysiology of diabetes mellitus.
Methods: In the present study, 68 patients with type 2 diabetes mellitus and 31 clinically …

Metabolic syndrome is a cluster of pathologies and conditions such as obesity,
hyperglycemia, hyperlipidemia and hypertension representing a serious health concern in …

Exposure to fine particular matter (PM2. 5) increases the risk of developing cardiovascular
disease and Type 2 diabetes. Because blood vessels are sensitive targets of air pollutant …